Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
+3,602
New +$947K 0.11% 288
2026
Q1
Sell
-1,366
Closed -$343K 1143
2025
Q4
$343K Buy
+1,366
New +$363K 0.08% 396
2025
Q2
Sell
-1,947
Closed -$453K 683
2025
Q1
$453K Buy
+1,947
New +$472K 0.18% 207
2024
Q4
Sell
-6,958
Closed -$1.55M 544
2024
Q3
$1.55M Buy
+6,958
New +$1.53M 0.47% 42
2024
Q2
Sell
-1,660
Closed -$363K 602
2024
Q1
$363K Sell
1,660
-2,740
-62% -$604K 0.09% 387
2023
Q4
$1M Buy
+4,400
New +$924K 0.27% 121

Other funds holding LH

AXQ Capital's LH Position: Q2 2026 in Review

AXQ Capital opened a new position in Labcorp (LH) in Q2 2026: 3,602 shares worth $1.01M. The stake represents 0.11% of the portfolio and ranks #288 among its holdings. This is a return to the name: AXQ Capital previously reported a position in LH as recently as Q4 2025.

AXQ Capital first reported a position in LH in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.55M in Q3 2024. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • AXQ Capital held 3,602 shares of Labcorp worth $1.01M as of Q2 2026.
  • Labcorp was a new AXQ Capital position in Q2 2026.
  • Labcorp made up 0.11% of AXQ Capital's portfolio in Q2 2026, its #288 holding.
  • AXQ Capital first reported a position in Labcorp in Q4 2023 and has held it in 6 quarters since.
  • AXQ Capital's Labcorp position peaked at $1.55M in Q3 2024.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.